• 1985 Citations
  • 23 Scopus h-Index
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Saranya Chumsri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Carryover effects of aromatase inhibitors in prevention

Chumsri, S. & Thompson, E. A., Jan 11 2020, In : The Lancet. 395, 10218, p. 91-92 2 p.

Research output: Contribution to journalComment/debate

Open Access

Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature

Chumsri, S., Sokol, E. S., Soyano-Muller, A. E., Parrondo, R. D., Reynolds, G. A., Nassar, A. & Thompson, E. A., May 1 2020, In : Journal of the National Comprehensive Cancer Network : JNCCN. 18, 5, p. 517-521 5 p.

Research output: Contribution to journalArticle

Open Access
  • Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

    Eiger, D., Pondé, N. F., Agbor-Tarh, D., Moreno-Aspitia, A., Piccart, M., Hilbers, F. S., Werner, O., Chumsri, S., Dueck, A., Kroep, J. R., Gomez, H., Láng, I., Rodeheffer, R. J., Ewer, M. S., Suter, T. & de Azambuja, E., May 12 2020, In : British journal of cancer. 122, 10, p. 1453-1460 8 p.

    Research output: Contribution to journalArticle

  • Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial

    Asleh, K., Brauer, H. A., Sullivan, A., Lauttia, S., Lindman, H., Nielsen, T. O., Joensuu, H., Thompson, E. A. & Chumsri, S., Jun 1 2020, In : Clinical Cancer Research. 26, 11, p. 2603-2614 12 p.

    Research output: Contribution to journalArticle

  • Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine

    Knutson, K. L., Block, M. S., Norton, N., Erskine, C. L., Hobday, T. J., Dietz, A. B., Padley, D., Gustafson, M. P., Puglisi-Knutson, D., Mangskau, T. K., Chumsri, S., Dueck, A. C., Karyampudi, L., Wilson, G. & Degnim, A. C., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1045-1053 9 p.

    Research output: Contribution to journalArticle